from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2515c/-

LFCtreatmentdescriptionclass of inhibitor

-0.703

Amikacinug/mL Amikacintranslation

0.213

Cap5-10ug/mL Capreomycintranslation

0.283

Rox10-50 ug/mL Roxithromycintranslation

-0.399

SM2-5 ug/mL Streptomycintranslation

-1.920

Tet5-10 ug/mL Tetracyclinetranslation

-1.248

Rif0.2-5ug/mL Rifampicintranscription

-0.559

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.024

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.466

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.002

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.755

Clofazimine10-13 ug/mL Clofaziminerespiration

0.013

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.425

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.650

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.256

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.060

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.171

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.266

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.908

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.386

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.044

KCN5-20 ug/mL Potassium cyaniderespiration

0.088

NaN30.2-2 mM Sodium aziderespiration

-0.761

Nigericin50 uM Nigericinrespiration

0.645

TRC10-150 ug/mL Triclosanrespiration

-0.096

TRZ10-25 ug/mL Thioridazinerespiration

1.094

Valinomycin0.5-10 uM Valinomycinrespiration

-1.232

ZnSO42 mM ZnSO4respiration

-0.401

menadione6-10 ug/mL Menadionerespiration

-1.076

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.257

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.094

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.034

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.120

NRP_1Non-replicating persistence stage 1dosRassociated

0.917

Amp0.2mg/mL AmpicillincellWall

0.585

Cephalexin20-100 ug/mL CephalexincellWall

1.020

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.623

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.303

EMB10-20 ug/mL EthambutolcellWall

1.340

Eta12-40 ug/mL EthionamidecellWall

0.867

INH0.2-0.4 ug/mL IsoniazidcellWall

0.906

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.139

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.222

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.990

BZA0.12 mg/mL BenzamidearomaticAmides

0.360

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.258

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.829

H2O24 mM hydrogen peroxideDNAdamaging

-0.042

Levo10 ug/mL LevofloxacinDNAdamaging

-0.953

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.269

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.494

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.376

UVUV-irradiationDNAdamaging

-0.470

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.408

Antimycin12.5-50 ug/mL Antimycin A?

0.389

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.312

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.561

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.516

PA8240.2-2 ug/mL PA-824?

0.545

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.283

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.042

Verapamil50 uM Verapamil?

-0.116

mercaptoethanol2 mM 2-Mercaptoethanol?

0.007

methoxatin10-20 ug/mL Methoxatin?